NFKB1 and skin squamous cell carcinoma: DHA was found to significantly inhibit activation of the NF-κB/HIF-1α/VEGF pathway in A431 cells, suggesting that DHA has a therapeutic effect in cSCC by inhibiting the NF-κB/HIF-1α/VEGF pathway.